Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Status:
Completed
Trial end date:
2017-06-13
Target enrollment:
Participant gender:
Summary
A Phase 2 Multi center, Randomized, Controlled, Double-Masked Clinical Trial Designed To
Evaluate The Safety And Exploratory Efficacy Of Luminate® (Alg-1001) As Compared To Avastin®
In The Treatment Of Diabetic Macular Edema